Notes - Segment Information

Astellas Pharma Inc. - Filing #7595393

Concept 2022-04-01 to
2022-06-30
As at
2022-06-30
As at
2022-03-31
2021-04-01 to
2021-06-30
Notes - Segment information
Segment information
Revenue
Revenue
381,791,000,000 JPY
326,143,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
350,000,000 JPY
292,000,000 JPY
Profit (loss) before tax
31,679,000,000 JPY
35,830,000,000 JPY
Assets
2,481,843,000,000 JPY
2,332,395,000,000 JPY
Investments accounted for using equity method
11,735,000,000 JPY
10,035,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.